---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-109371"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2021-08-25T23:59:59+00:00"
generated_at: "2026-06-29T07:46:45.344867+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Brainstorm CFO Preetam Shah resigns, Controller Alla Patlis named Interim CFO

## Summary
- CFO Preetam Shah resigned effective Aug 31, 2021; no disagreement with the Company or Board.
- Controller Alla Patlis appointed Interim CFO effective upon Shah's departure if no permanent CFO named.
- Patlis has served as Controller since Dec 2012 and previously as Interim CFO in 2015 and 2016-2017.
- No change in Patlis's current compensation for the additional Interim CFO role.
- Company plans to interview candidates for a permanent CFO successor.

## SEC filing metadata
- accession: 0001104659-21-109371
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2021-08-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/0001104659-21-109371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/tm2125922d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-109371
- JSON: https://secwatch.observer/filing/0001104659-21-109371.json
- Plain text: https://secwatch.observer/filing/0001104659-21-109371.txt

## Key facts
- Executive change
  Preetam Shah resigned as Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On August 20, 2021, Preetam Shah, the Chief Financial Officer (and principal financial and accounting officer) of Brainstorm Cell Therapeutics Inc. (the “Company”), provided the Company with notice of his intent to resign from the Company, effective August 31, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/0001104659-21-109371-index.htm
- Executive change
  Alla Patlis was appointed as Interim Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: The Board of Directors of the Company has appointed Alla Patlis, the Company’s current Controller, as the Company’s Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective upon Mr. Shah’s resignation if a permanent Chief Financial Officer is not appointed prior to that time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/0001104659-21-109371-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.